[Skip to Content]
[Skip to Content Landing]
Views 163
Citations 0
Teachable Moment
Sharing Medicine
December 21, 2018

Nitroimidazole Resistance in Trichomonas vaginalis Infection: A Teachable Moment

Author Affiliations
  • 1Johns Hopkins University School of Medicine, Baltimore, Maryland
JAMA Intern Med. Published online December 21, 2018. doi:10.1001/jamainternmed.2018.7241

A previously healthy woman in her 30s presented to an infectious diseases clinic for evaluation of persistent Trichomonas vaginalis infection. She had developed vaginal discharge and irritation 2 years earlier after sexual intercourse with a male partner. She was diagnosed with trichomoniasis and treated with oral metronidazole, 2 g, in a single dose. However, her symptoms did not resolve. Over the course of the next 8 months she returned at least 6 times and saw different health care providers for treatment of persistent discharge. Each time, samples were sent for microscopy or nucleic acid amplification testing (NAAT), test results were positive for T vaginalis, and she was treated with different nitroimidazole regimens. In sequence, these treatments included oral metronidazole, 500 mg, twice daily for 7 days; oral tinidazole, 2 g, once daily for 5 days; oral metronidazole, 500 mg, twice daily plus intravaginal metronidazole for 7 days; oral tinidazole, 2 g, once; oral tinidazole, 2 g, once daily for 5 days; and oral metronidazole, 2 g, daily for 5 days.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×